Fundz

Rani Therapeutics, Llc reported raising $50 Million in an initial SEC Form D filing, from an offering of $75 Million

PRIVATENov 16, 2020$50M of $75M raised

Amount Raised

$50 Million

$50 Million sold, per SEC Form D (first sale Nov 16, 2020)

Round Type

Venture

San JoseBiotechnologyHealthcare

Quick answer

Rani Therapeutics raised $50 Million in a funding round, dated November 16, 2020. Rani Therapeutics is based in San Jose, California, United States.

How much did Rani Therapeutics raise?
Rani Therapeutics raised $50 Million in a funding round on November 16, 2020.
What does Rani Therapeutics do?
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs.
Where is Rani Therapeutics based and how big is it?
Rani Therapeutics is based in San Jose, California, United States. Fundz records about 110 employees.
Who are the decision-makers at Rani Therapeutics?
Fundz holds 5 contacts at Rani Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Rani Therapeutics that raised within 45 days of this round, from Fundz verified event records.

Who to call at Rani Therapeutics, and when

A new round usually means Rani Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rani Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rani Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rani Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rani Therapeutics

Location

2051 RINGWOOD AVENUE

San Jose, California, United States

About

Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs, the vast majority of which must be injected. We have developed the RaniPill™ technology to replace subcutaneous or IV injections of biologics with an oral pill. The RaniPill™ capsule is designed to deliver an injection to the intestinal wall, where there are no sharp pain receptors, and has achieved bioavailability similar to subcutaneous injections. We believe oral versions of biologics will have the potential to transform medicine and improve outcomes for the millions of patients who currently rely on chronic self-injections.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rani Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

5 contacts
Verified contactsTalat I., Chief Executive Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Rani Therapeutics's next move

See what Strategic adds

Rani Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.